Replies to post #110534 on Biotech Values

[masterlongevity]

how are RRMS clinical trial patients still getting placebos? all of these trials should now be required to have an active comparator.. there are too many good therapies on the market to continue the use of placebo only as the control.

[DewDiligence]

Data from the ALLEGRO study of Teva’s Laquinimod will be presented on a webcast April 14:

http://finance.yahoo.com/news/Teva-Announces-Webcast-on-bw-1372651538.html?x=0&.v=1

The second phase-3 Laquinimod study (BRAVO) is due to report data in 3Q11.